January 2024 - Vielight Inc

Vielight Featured in USA Today!

Vielight featured in USA Today for Alzheimer's and Parkinsons' Research! We were recently featured in USA Today! This independent article covers the modern day challenges that humanity faces and how our Vielight Neuro is being used in cutting-edge photobiomodulation research to study the effects of optimized, high-powered NIR energy delivery to the brain. This [...]

Viral and Immunity Recovery Results | Vielight RX-Plus Major Clinical Trial (n=294) | Health Canada Medical Device License

These results are based on a major viral recovery clinical trial (n=294) conducted with the Vielight RX-Plus 4 PUBLISHED RESEARCH The Vielight RX-Plus is the only PBM device supported by published clinical results for viral recovery and inflammatory-based immunity (September 2024). Health Canada medical device license indication: "The Vielight RX Plus is [...]

Illuminating the Brain | The Vielight Neuro’s Energy Footprint | Full Transcranial-Intranasal Footprint

Illuminating the Brain | The Vielight Neuro’s Energy Footprint | Full Transcranial-Intranasal Footprint

Vielight Featured in USA Today!

Viral and Immunity Recovery Results | Vielight RX-Plus Major Clinical Trial (n=294) | Health Canada Medical Device License